Chief Science Advisor

Dr. Eric Raabe, M.D., Ph.D,  Johns Hopkins Associate Professor of Oncology

Dr. Raabe brings a wealth of knowledge and experience in the pediatric oncology field. He has spent over a decade at Johns Hopkins as a Fellow, Instructor, and Professor in the pediatric oncology department. Dr. Raabe has helped to create genetically accurate models of pediatric brain tumors while working in the laboratory of Dr. Charles Eberhart in Neuropathology. Prior to joining Johns Hopkins Dr. Raabe spent a year in Africa as part of the Baylor International Pediatric AIDS Initiative. Dr. Raabe received his M.D. and Ph.D. from the University Of Cincinnati College Of Medicine and completed his Residency at the Children’s Hospital of Philadelphia.

Dr. Raabe shares IAA’s commitment to discovering new and more effective treatments for pediatric cancer patients. “We are using 1980s therapy to treat patients today,” he says. Dr. Raabe and IAA share a commitment to find innovative new treatments that will not only fight PLGAs but will also improve the quality of life for patients.

Dr. Raabe’s position as Chief Science Advisor is the latest step in his partnership with Imagine An Answer. Using Imagine An Answer funds Dr. Raabe has been conducting research focused on finding a cure for PLGAs. Dr. Raabe and his team’s work has been crucial in developing models that will help us find new therapies for patients.

James “J.D.” Derderian


J.D. Derderian has nearly three decades of experience working with Congressional and White House leadership.

J.D. is the founder and managing partner of the Stanton Park Group. His issue expertise is in healthcare, energy, technology, and telecommunications.   As Chief of Staff to the House Committee on Energy and Commerce, Mr. Derderian served as the principal strategist and advisor to the Committee with jurisdiction over a wide array of economy drivers – healthcare, technology, energy, and finance.  Mr. Derderian successfully guided passage of historic legislation such as the Food and Drug Administration Modernization, the Balanced Budget Act of 1997, and the Telecommunications Reform of 1996.  In addition, he led the oversight of the many agencies and departments under the Committee’s purview such as the Department of Health and Human Services, the Department of Commerce, the Centers for Medicare and Medicaid Services, and the Food and Drug Administration.

Mr. Derderian graduated cum laude with a B.A. from the University of Richmond.




Lloyd K. Everson, M.D.


Dr. Everson served as President, Vice-Chairman and member of the Board of Directors of US Oncology, Inc. until is acquisition by McKesson Inc. in 2010.  In 1993, Dr. Everson became a member of the Board of Directors, President, and Chief Operating Officer of American Oncology Resources, Inc., which was the predecessor organization of US Oncology, Inc.

From August 2013 until October, 2014, Dr. Everson served as President and CEO of Molecular Health, Inc.

Dr. Everson has served in numerous leadership roles in medical education throughout his career, including the practice of oncology and hematology, cancer research, academic and administrative medicine.

Dr. Everson graduated from Harvard Medical School in 1969. His postgraduate education included clinical and research positions at Cornell Medical Center & New York Hospital, NYC, NY, Memorial Sloan Kettering Cancer Center in NYC and at the National Cancer Institute in Washington, DC.


Caroline Jones Hubbell

Caroline HubbellMs. Hubbell spent 20 years working in advertising both in Washington, D.C. and New York, N.Y.  She served on the board of The Paper Bag Players and as a member of the Vestry at Grace Church New York City.  Currently, Caroline works as an Admissions Associate at The Ethical Culture Fieldston School.  She lives in Bronxville, NY and is a graduate of Emory University.






Amit K. Sachdev


Amit K. Sachdev is Chief Regulatory Officer at Vertex Pharmaceuticals, where he has served
over the past decade in numerous executive leadership roles spanning the business as a
corporate officer and member of the executive leadership team. During this time, the
Company has experienced seven-fold growth and successfully developed and commercialized
three novel breakthrough medicines for patients with serious liver disease and for patients with
a life-threatening lung disease called cystic fibrosis. Today, Vertex is one of the world’s leading
global biotechnology companies with its headquarters in Boston, Massachusetts and London,

Over the prior decade, Mr. Sachdev held various senior executive appointments in government both at the U.S. Food and Drug Administration and in the U.S House of Representatives. He also practiced law first at the American Chemistry Council and then at the law firm of Ropes and Gray. Amit serves on several non-profit and philanthropic boards, including MassBIO, a biotechnology innovation association in Massachusetts and  Imagine An Answer.   In 2017, he joined the Board of Advisors for the Stanford Center for Longevity Studies.

Mr. Sachdev received a B.S from Carnegie Mellon University and a J.D. from Emory University School of Law.



Brian Duggan

dugganBrian Duggan is Minority Owner/Board Member at Apex Clearing Corporation and also serves as Managing Member at Woodland & West, LLC, which offers investing and consulting services in the financial industry.  

Previously, Mr. Duggan served for more than 22 years as CEO of Goldman Sachs Execution & Clearing, LP.  While Head of Goldman Sachs Global Clearing business, Mr. Duggan provided professional trading clients access to all listed exchanges, financing and risk management for their strategies.
He is a graduate of Miami University, where he received a BS in Finance.



Elise K. Aronson


Elise K. Aronson is Vice President, Government Relations for MacAndrews & Forbes Incorporated, a private diversified holding company with interests in a broad portfolio of publicly traded and privately held companies. Wholly owned by Chairman and Chief Executive Officer Ronald O. Perelman, MacAndrews & Forbes invests in companies with strong market positions, recognized brands, and growth potential.

Prior to her current position, Elise spent over twelve years on Capitol Hill, working for the then-House International Relations Committee. She left the Committee to work for Congressman Howard P. “Buck” McKeon (R-CA) as a Legislative Assistant, covering military and health issues. In 2000, Elise joined the office of Congressman Jim Saxton (R-NJ) as the Legislative Director, responsible for managing the legislative staff in his Washington office and was promoted to Chief of Staff, overseeing all of his legislative and political operations in Washington, serving this in capacity until 2008.

Elise is a graduate of American University in Washington, DC, where she obtained a B.A. in International Relations.


Cindy Nachman-Senders

Cindy Nachman-Senders is the President of CNS Consulting Group, a full-service corporate and association events-planning company.  CNS Consulting Group’s expertise includes hotel, venue, and vendor contract negotiation, programming and content, staging and production, marketing, branding, print and digital design, tradeshows and expositions, special events, and sales incentive programs.

Cindy worked for the American Institute of Ultrasound in Medicine and the National Food Processors Association before starting her own firm in 2001.

She is on the Marriott Luxury Collection Association Advisory Board.  Cindy holds a Bachelor’s of Science in Public Health with a minor in marketing from the University of Maryland, College Park.